Muscular Atrophy
12 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Nervous System Diseases
Narrower: Sarcopenia 6
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| AAV9-Follistatin gene therapy for sarcopenia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AAV9-Follistatin gene therapy + VEGF Plasmid for sarcopenia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Apitegromab for muscular atrophy | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Essential Amino Acid Supplementation for muscular atrophy | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| MF-300 for sarcopenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| OAV101 for muscular atrophy | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Onasemnogene abeparvovec for muscular atrophy | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oxytocin for sarcopenia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo Nasal Spray for sarcopenia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Silkworm pupa tablets for sarcopenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Total knee replacement for muscular atrophy | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Unicompartmental knee replacement for muscular atrophy | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.